ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR)

CUSIP: 04280A100

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
+1,251,194
Put/Call ratio
119%
SEC-reported price per share
$45.99
Number of holders
294
Value change
+$35,685,819
Number of buys
148
Show 1 more signal
Number of sells
132
Security identity 1 source field
Shares outstanding
141,328,976

Security key

04280A100

Report period

Q1 2022

Institutions

294

Top holders

10

Ownership snapshot

Top reported holders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F Lead comparable stake: 8.5% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 8.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5
BlackRock Finance, Inc. 8.5%
VANGUARD GROUP INC 6.8%
STATE STREET CORP 2.8%
JOHNSON & JOHNSON 2.3%
JPMORGAN CHASE & CO 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
8.5%
$796,135,000
12,008,063 shares
31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
6.8%
$639,142,000
9,640,143 shares
31 Dec 2021
STATE STREET CORP
13F
Company
13F
2.8%
$258,886,000
3,904,771 shares
31 Dec 2021
JOHNSON & JOHNSON
13F
Company
13F
2.3%
$216,196,000
3,260,869 shares
31 Dec 2021
JPMORGAN CHASE & CO
13F
Company
13F
2.1%
$197,511,000
2,979,064 shares
31 Dec 2021
ALLIANCEBERNSTEIN L.P.
13F
Company
13F
1.7%
$163,397,000
2,464,511 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
294
Shares
69,254,530
Rows available
294
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
297
Q1 2022 holders
294
Holder diff
-3
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .